Trial intelligence / Profile preview

Mother's Recorded Voice vs Dexmedetomidine for Pediatric Postoperative Agitation

NCT04941508Phase 3Completed

Sponsor
Assiut University
Start
Jun 2021
Primary completion
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of dexmedetomidine in Emergence agitation (EA) (3 arms), sponsored by Assiut University. Primary endpoint: Pediatric Anesthesia Emergence Delirium. Started Jun 2021; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on NCT04941508.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04941508.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call